<?xml version="1.0" encoding="UTF-8"?>
<!-- このサイトマップは、2026年6月22日の3:28 PMに、WordPress 用のオリジナル SEO プラグイン All in One SEO v4.6.5により動的生成されました。 -->

<?xml-stylesheet type="text/xsl" href="https://czeek.com/default-sitemap.xsl"?>

<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
	<channel>
		<title>CzeekV インデックス</title>
		<link><![CDATA[https://czeek.com]]></link>
		<description><![CDATA[CzeekV インデックス]]></description>
		<lastBuildDate><![CDATA[Mon, 15 Jun 2026 08:08:26 +0000]]></lastBuildDate>
		<docs>https://validator.w3.org/feed/docs/rss2.html</docs>
		<atom:link href="https://czeek.com/sitemap.rss" rel="self" type="application/rss+xml" />
		<ttl><![CDATA[60]]></ttl>

		<item>
			<guid><![CDATA[https://czeek.com/information-883/]]></guid>
			<link><![CDATA[https://czeek.com/information-883/]]></link>
			<title>論文・技術情報追加のお知らせ</title>
			<pubDate><![CDATA[Mon, 15 Jun 2026 08:08:26 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://czeek.com/ronbun/unfilled-prescriptions-in-japan-a-10-year-retrospective-analysis/]]></guid>
			<link><![CDATA[https://czeek.com/ronbun/unfilled-prescriptions-in-japan-a-10-year-retrospective-analysis/]]></link>
			<title>Unfilled Prescriptions in Japan: A 10-Year Retrospective Analysis.</title>
			<pubDate><![CDATA[Mon, 15 Jun 2026 06:16:15 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://czeek.com/ronbun/comparison-of-renal-prognosis-between-dipeptidyl-peptidase-4-inhibitor-users-and-non-users/]]></guid>
			<link><![CDATA[https://czeek.com/ronbun/comparison-of-renal-prognosis-between-dipeptidyl-peptidase-4-inhibitor-users-and-non-users/]]></link>
			<title>Comparison of renal prognosis between dipeptidyl peptidase-4 inhibitor users and non-users.</title>
			<pubDate><![CDATA[Mon, 15 Jun 2026 06:16:15 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://czeek.com/ronbun/tooth-extraction-dental-visits-and-glucose-levels-a-retrospective-study/]]></guid>
			<link><![CDATA[https://czeek.com/ronbun/tooth-extraction-dental-visits-and-glucose-levels-a-retrospective-study/]]></link>
			<title>Tooth Extraction, Dental Visits, and Glucose Levels: a Retrospective Study.</title>
			<pubDate><![CDATA[Mon, 15 Jun 2026 06:16:13 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://czeek.com/ronbun/predicted-lean-body-mass-and-the-risk-of-adverse-kidney-outcomes-in-men/]]></guid>
			<link><![CDATA[https://czeek.com/ronbun/predicted-lean-body-mass-and-the-risk-of-adverse-kidney-outcomes-in-men/]]></link>
			<title>Predicted Lean Body Mass and the Risk of Adverse Kidney Outcomes in Men.</title>
			<pubDate><![CDATA[Mon, 15 Jun 2026 06:16:10 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://czeek.com/ronbun/unveiling-the-limits-of-anticholinergic-burden-scales-a-study-of-adverse-drug-reactions-in-the-french-pharmacovigilance-database/]]></guid>
			<link><![CDATA[https://czeek.com/ronbun/unveiling-the-limits-of-anticholinergic-burden-scales-a-study-of-adverse-drug-reactions-in-the-french-pharmacovigilance-database/]]></link>
			<title>Unveiling the Limits of Anticholinergic Burden Scales: A Study of Adverse Drug Reactions in the French Pharmacovigilance Database.</title>
			<pubDate><![CDATA[Mon, 15 Jun 2026 06:16:08 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://czeek.com/ronbun/characteristics-all-cause-healthcare-resource-utilisation-and-costs-among-high-risk-adults-with-long-covid-during-omicron-predominance-2022-2023-a-retrospective-cohort-study-using-uk-primary-care/]]></guid>
			<link><![CDATA[https://czeek.com/ronbun/characteristics-all-cause-healthcare-resource-utilisation-and-costs-among-high-risk-adults-with-long-covid-during-omicron-predominance-2022-2023-a-retrospective-cohort-study-using-uk-primary-care/]]></link>
			<title>Characteristics, all-cause healthcare resource utilisation, and costs among high-risk adults with long COVID during Omicron predominance, 2022-2023: a retrospective cohort study using UK primary care data.</title>
			<pubDate><![CDATA[Mon, 15 Jun 2026 06:16:08 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://czeek.com/ronbun/safety-of-remibrutinib-in-chronic-spontaneous-urticaria-a-pooled-analysis-of-remix-1-and-remix-2-trials/]]></guid>
			<link><![CDATA[https://czeek.com/ronbun/safety-of-remibrutinib-in-chronic-spontaneous-urticaria-a-pooled-analysis-of-remix-1-and-remix-2-trials/]]></link>
			<title>Safety of remibrutinib in chronic spontaneous urticaria: a pooled analysis of REMIX-1 and REMIX-2 trials.</title>
			<pubDate><![CDATA[Mon, 15 Jun 2026 06:16:08 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://czeek.com/ronbun/evaluating-the-comparability-of-osteoporosis-treatments-using-propensity-score-and-negative-control-outcome-methods-in-uk-and-denmark-electronic-health-record-databases/]]></guid>
			<link><![CDATA[https://czeek.com/ronbun/evaluating-the-comparability-of-osteoporosis-treatments-using-propensity-score-and-negative-control-outcome-methods-in-uk-and-denmark-electronic-health-record-databases/]]></link>
			<title>Evaluating the comparability of osteoporosis treatments using propensity score and negative control outcome methods in UK and Denmark electronic health record databases.</title>
			<pubDate><![CDATA[Mon, 15 Jun 2026 06:16:07 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://czeek.com/ronbun/predictive-value-of-abnormal-blood-tests-for-detecting-cancer-in-primary-care-patients-with-nonspecific-abdominal-symptoms-a-population-based-cohort-study-of-477870-patients-in-england/]]></guid>
			<link><![CDATA[https://czeek.com/ronbun/predictive-value-of-abnormal-blood-tests-for-detecting-cancer-in-primary-care-patients-with-nonspecific-abdominal-symptoms-a-population-based-cohort-study-of-477870-patients-in-england/]]></link>
			<title>Predictive value of abnormal blood tests for detecting cancer in primary care patients with nonspecific abdominal symptoms: A population-based cohort study of 477,870 patients in England.</title>
			<pubDate><![CDATA[Mon, 15 Jun 2026 06:16:07 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://czeek.com/ronbun/using-a-markov-model-and-real-world-evidence-to-identify-the-most-cost-effective-cholesterol-treatment-escalation-threshold-for-the-secondary-prevention-of-cardiovascular-disease/]]></guid>
			<link><![CDATA[https://czeek.com/ronbun/using-a-markov-model-and-real-world-evidence-to-identify-the-most-cost-effective-cholesterol-treatment-escalation-threshold-for-the-secondary-prevention-of-cardiovascular-disease/]]></link>
			<title>Using a Markov Model and Real-World Evidence to Identify the Most Cost-Effective Cholesterol Treatment Escalation Threshold for the Secondary Prevention of Cardiovascular Disease.</title>
			<pubDate><![CDATA[Mon, 15 Jun 2026 06:16:04 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://czeek.com/ronbun/maternal-postpartum-six-week-check-and-short-term-health-outcomes-for-women-with-hypertensive-disorders-in-pregnancy-an-observational-study-using-the-clinical-practice-research-datalink-cprd/]]></guid>
			<link><![CDATA[https://czeek.com/ronbun/maternal-postpartum-six-week-check-and-short-term-health-outcomes-for-women-with-hypertensive-disorders-in-pregnancy-an-observational-study-using-the-clinical-practice-research-datalink-cprd/]]></link>
			<title>Maternal postpartum six-week check and short-term health outcomes for women with hypertensive disorders in pregnancy: An observational study using the Clinical Practice Research Datalink (CPRD).</title>
			<pubDate><![CDATA[Mon, 15 Jun 2026 06:16:03 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://czeek.com/ronbun/variations-in-social-care-need-reporting-amongst-gp-practices-in-england-a-retrospective-cohort-study-in-people-with-multimorbidity/]]></guid>
			<link><![CDATA[https://czeek.com/ronbun/variations-in-social-care-need-reporting-amongst-gp-practices-in-england-a-retrospective-cohort-study-in-people-with-multimorbidity/]]></link>
			<title>Variations in social care need reporting amongst GP practices in England: a retrospective cohort study in people with multimorbidity.</title>
			<pubDate><![CDATA[Mon, 15 Jun 2026 06:16:00 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://czeek.com/ronbun/consultations-with-locum-doctors-in-uk-general-practice-longitudinal-analysis-of-electronic-health-records/]]></guid>
			<link><![CDATA[https://czeek.com/ronbun/consultations-with-locum-doctors-in-uk-general-practice-longitudinal-analysis-of-electronic-health-records/]]></link>
			<title>Consultations with locum doctors in UK general practice: longitudinal analysis of electronic health records.</title>
			<pubDate><![CDATA[Mon, 15 Jun 2026 06:16:00 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://czeek.com/ronbun/therapeutic-strategies-after-discontinuation-of-valproate-by-females-with-epilepsy-of-child-bearing-potential-an-insurance-claims-database-study-in-france-and-the-united-kingdom/]]></guid>
			<link><![CDATA[https://czeek.com/ronbun/therapeutic-strategies-after-discontinuation-of-valproate-by-females-with-epilepsy-of-child-bearing-potential-an-insurance-claims-database-study-in-france-and-the-united-kingdom/]]></link>
			<title>Therapeutic Strategies After Discontinuation of Valproate By Females with Epilepsy of Child-Bearing Potential: An Insurance Claims Database Study in France and the United Kingdom.</title>
			<pubDate><![CDATA[Mon, 15 Jun 2026 06:15:59 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://czeek.com/ronbun/a-multidimensional-framework-for-mapping-social-need-to-electronic-health-records-in-people-with-multimorbidity/]]></guid>
			<link><![CDATA[https://czeek.com/ronbun/a-multidimensional-framework-for-mapping-social-need-to-electronic-health-records-in-people-with-multimorbidity/]]></link>
			<title>A multidimensional framework for mapping social need to electronic health records in people with multimorbidity.</title>
			<pubDate><![CDATA[Mon, 15 Jun 2026 06:15:58 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://czeek.com/ronbun/cardiovascular-disease-risk-prediction-in-patients-with-metabolic-dysfunction-associated-steatohepatitis/]]></guid>
			<link><![CDATA[https://czeek.com/ronbun/cardiovascular-disease-risk-prediction-in-patients-with-metabolic-dysfunction-associated-steatohepatitis/]]></link>
			<title>Cardiovascular Disease Risk Prediction in Patients With Metabolic Dysfunction-Associated Steatohepatitis.</title>
			<pubDate><![CDATA[Mon, 15 Jun 2026 06:15:41 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://czeek.com/ronbun/pre-diagnostic-prescription-patterns-in-pancreatic-cancer-a-retrospective-cohort-study/]]></guid>
			<link><![CDATA[https://czeek.com/ronbun/pre-diagnostic-prescription-patterns-in-pancreatic-cancer-a-retrospective-cohort-study/]]></link>
			<title>Prediagnostic prescription patterns in pancreatic cancer: a retrospective primary care cohort study.</title>
			<pubDate><![CDATA[Mon, 15 Jun 2026 06:15:40 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://czeek.com/ronbun/development-and-validation-of-a-prediction-model-for-cardiovascular-risk-in-reproductive-aged-women/]]></guid>
			<link><![CDATA[https://czeek.com/ronbun/development-and-validation-of-a-prediction-model-for-cardiovascular-risk-in-reproductive-aged-women/]]></link>
			<title>Development and Validation of a Prediction Model for Cardiovascular Risk in Reproductive-Aged Women.</title>
			<pubDate><![CDATA[Mon, 15 Jun 2026 06:15:40 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://czeek.com/ronbun/prescribing-of-anti-dementia-medications-in-primary-care-a-retrospective-cohort-study-in-1489-english-general-practices/]]></guid>
			<link><![CDATA[https://czeek.com/ronbun/prescribing-of-anti-dementia-medications-in-primary-care-a-retrospective-cohort-study-in-1489-english-general-practices/]]></link>
			<title>Prescribing of anti-dementia medications in primary care: A retrospective cohort study in 1489 English General Practices.</title>
			<pubDate><![CDATA[Mon, 15 Jun 2026 06:15:40 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://czeek.com/ronbun/empirical-estimate-for-the-indirect-healthcare-costs-of-sickle-cell-disease-from-a-retrospective-cohort-study-in-england-between-2007-and-2019/]]></guid>
			<link><![CDATA[https://czeek.com/ronbun/empirical-estimate-for-the-indirect-healthcare-costs-of-sickle-cell-disease-from-a-retrospective-cohort-study-in-england-between-2007-and-2019/]]></link>
			<title>Empirical estimate for the indirect healthcare costs of sickle cell disease from a retrospective cohort study in England between 2007 and 2019.</title>
			<pubDate><![CDATA[Mon, 15 Jun 2026 06:15:38 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://czeek.com/ronbun/trends-in-second-line-initiations-and-treatment-outcomes-across-age-and-frailty-groups-in-people-with-type-2-diabetes-uk-population-based-study-2019-2024/]]></guid>
			<link><![CDATA[https://czeek.com/ronbun/trends-in-second-line-initiations-and-treatment-outcomes-across-age-and-frailty-groups-in-people-with-type-2-diabetes-uk-population-based-study-2019-2024/]]></link>
			<title>Trends in Second-Line Initiations and Treatment Outcomes Across Age and Frailty Groups in People With Type 2 Diabetes: UK Population-Based Study, 2019-2024.</title>
			<pubDate><![CDATA[Mon, 15 Jun 2026 06:15:38 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://czeek.com/ronbun/a-machine-learning-approach-to-predict-additional-treatment-after-bacillus-calmette-guerin-induction-in-non-muscle-invasive-bladder-cancer/]]></guid>
			<link><![CDATA[https://czeek.com/ronbun/a-machine-learning-approach-to-predict-additional-treatment-after-bacillus-calmette-guerin-induction-in-non-muscle-invasive-bladder-cancer/]]></link>
			<title>A machine-learning approach to predict additional treatment after Bacillus Calmette-Guerin induction in non-muscle-invasive bladder cancer.</title>
			<pubDate><![CDATA[Mon, 15 Jun 2026 06:15:33 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://czeek.com/ronbun/association-of-hypoglycemic-agents-with-the-risk-of-platinum-based-chemotherapy-induced-peripheral-neuropathy-in-patients-with-type-2-diabetes-mellitus/]]></guid>
			<link><![CDATA[https://czeek.com/ronbun/association-of-hypoglycemic-agents-with-the-risk-of-platinum-based-chemotherapy-induced-peripheral-neuropathy-in-patients-with-type-2-diabetes-mellitus/]]></link>
			<title>Association of Hypoglycemic Agents with the Risk of Platinum-Based Chemotherapy-Induced Peripheral Neuropathy in Patients with Type 2 Diabetes Mellitus.</title>
			<pubDate><![CDATA[Mon, 15 Jun 2026 06:15:32 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://czeek.com/ronbun/contemporary-description-of-clinical-characteristics-and-outcomes-in-patients-with-hereditary-attr-amyloidosis-results-from-the-multicountry-overtture-study/]]></guid>
			<link><![CDATA[https://czeek.com/ronbun/contemporary-description-of-clinical-characteristics-and-outcomes-in-patients-with-hereditary-attr-amyloidosis-results-from-the-multicountry-overtture-study/]]></link>
			<title>Contemporary Description of Clinical Characteristics and Outcomes in Patients with Hereditary ATTR Amyloidosis: Results from the Multicountry OverTTuRe Study.</title>
			<pubDate><![CDATA[Mon, 15 Jun 2026 06:15:32 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://czeek.com/ronbun/definitions-and-prognoses-of-persistent-inflammation-immunosuppression-and-catabolism-syndrome-a-comparative-analysis-via-systematic-review-and-observational-study-in-japan/]]></guid>
			<link><![CDATA[https://czeek.com/ronbun/definitions-and-prognoses-of-persistent-inflammation-immunosuppression-and-catabolism-syndrome-a-comparative-analysis-via-systematic-review-and-observational-study-in-japan/]]></link>
			<title>Definitions and Prognoses of Persistent Inflammation, Immunosuppression, and Catabolism Syndrome: A Comparative Analysis via Systematic Review and Observational Study in Japan.</title>
			<pubDate><![CDATA[Mon, 15 Jun 2026 06:15:32 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://czeek.com/ronbun/contemporary-use-of-oral-inotropes-in-the-outpatient-treatment-of-heart-failure-analysis-of-a-japanese-nationwide-database/]]></guid>
			<link><![CDATA[https://czeek.com/ronbun/contemporary-use-of-oral-inotropes-in-the-outpatient-treatment-of-heart-failure-analysis-of-a-japanese-nationwide-database/]]></link>
			<title>Contemporary Use of Oral Inotropes in the Outpatient Treatment of Heart Failure: Analysis of a Japanese Nationwide Database.</title>
			<pubDate><![CDATA[Mon, 15 Jun 2026 06:15:31 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://czeek.com/ronbun/association-between-modifiable-lifestyle-factors-and-the-incidences-of-sudden-sensorineural-hearing-loss-and-menieres-disease-a-population-based-nested-case-control-study/]]></guid>
			<link><![CDATA[https://czeek.com/ronbun/association-between-modifiable-lifestyle-factors-and-the-incidences-of-sudden-sensorineural-hearing-loss-and-menieres-disease-a-population-based-nested-case-control-study/]]></link>
			<title>Association between modifiable lifestyle factors and the incidences of sudden sensorineural hearing loss and Meniere&#8217;s disease: A population-based nested case-control study.</title>
			<pubDate><![CDATA[Mon, 15 Jun 2026 06:15:29 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://czeek.com/ronbun/trends-demographic-characteristics-and-seasonal-patterns-of-nonoperative-and-operative-reduction-for-intussusception-a-preliminary-nationwide-claims-based-analysis-from-2014-to-2023-in-japan/]]></guid>
			<link><![CDATA[https://czeek.com/ronbun/trends-demographic-characteristics-and-seasonal-patterns-of-nonoperative-and-operative-reduction-for-intussusception-a-preliminary-nationwide-claims-based-analysis-from-2014-to-2023-in-japan/]]></link>
			<title>Trends, Demographic Characteristics, and Seasonal Patterns of Nonoperative and Operative Reduction for Intussusception: A Preliminary Nationwide Claims-Based Analysis from 2014 to 2023 in Japan.</title>
			<pubDate><![CDATA[Mon, 15 Jun 2026 06:15:29 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://czeek.com/ronbun/impact-of-potentially-inappropriate-medications-on-emergency-ambulance-admissions-in-geriatric-patients-after-discharge/]]></guid>
			<link><![CDATA[https://czeek.com/ronbun/impact-of-potentially-inappropriate-medications-on-emergency-ambulance-admissions-in-geriatric-patients-after-discharge/]]></link>
			<title>Impact of potentially inappropriate medications on emergency ambulance admissions in geriatric patients after discharge.</title>
			<pubDate><![CDATA[Mon, 15 Jun 2026 06:15:28 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://czeek.com/ronbun/periodontal-care-is-associated-with-a-lower-risk-of-dialysis-initiation-in-middle-aged-patients-with-type-2-diabetes-mellitus-a-6-year-follow-up-cohort-study-based-on-a-nationwide-healthcare-database/]]></guid>
			<link><![CDATA[https://czeek.com/ronbun/periodontal-care-is-associated-with-a-lower-risk-of-dialysis-initiation-in-middle-aged-patients-with-type-2-diabetes-mellitus-a-6-year-follow-up-cohort-study-based-on-a-nationwide-healthcare-database/]]></link>
			<title>Periodontal Care Is Associated With a Lower Risk of Dialysis Initiation in Middle-Aged Patients With Type 2 Diabetes Mellitus: A 6-Year Follow-Up Cohort Study Based on a Nationwide Healthcare Database.</title>
			<pubDate><![CDATA[Mon, 15 Jun 2026 06:15:27 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://czeek.com/ronbun/cost-effectiveness-analysis-of-anamorelin-and-olanzapine-for-cancer-cachexia-in-non-small-cell-lung-cancer-patients-in-japan/]]></guid>
			<link><![CDATA[https://czeek.com/ronbun/cost-effectiveness-analysis-of-anamorelin-and-olanzapine-for-cancer-cachexia-in-non-small-cell-lung-cancer-patients-in-japan/]]></link>
			<title>Cost-Effectiveness Analysis of Anamorelin and Olanzapine for Cancer Cachexia in Non-Small Cell Lung Cancer Patients in Japan.</title>
			<pubDate><![CDATA[Mon, 15 Jun 2026 06:15:27 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://czeek.com/ronbun/in-hospital-outcomes-of-lacosamide-versus-levetiracetam-for-early-adjunctive-treatment-of-status-epilepticus-a-nationwide-japanese-retrospective-cohort-study/]]></guid>
			<link><![CDATA[https://czeek.com/ronbun/in-hospital-outcomes-of-lacosamide-versus-levetiracetam-for-early-adjunctive-treatment-of-status-epilepticus-a-nationwide-japanese-retrospective-cohort-study/]]></link>
			<title>In-hospital outcomes of lacosamide versus levetiracetam for early adjunctive treatment of status epilepticus: A Nationwide Japanese retrospective cohort study.</title>
			<pubDate><![CDATA[Mon, 15 Jun 2026 06:15:26 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://czeek.com/ronbun/treatments-and-outcomes-of-neonatal-disseminated-intravascular-coagulation-with-and-without-neonatal-asphyxia-a-retrospective-study-using-nationwide-data-in-japan/]]></guid>
			<link><![CDATA[https://czeek.com/ronbun/treatments-and-outcomes-of-neonatal-disseminated-intravascular-coagulation-with-and-without-neonatal-asphyxia-a-retrospective-study-using-nationwide-data-in-japan/]]></link>
			<title>Treatments and outcomes of neonatal disseminated intravascular coagulation with and without neonatal asphyxia: A retrospective study using nationwide data in Japan.</title>
			<pubDate><![CDATA[Mon, 15 Jun 2026 06:15:26 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://czeek.com/ronbun/after-total-hip-arthroplasty-patients-with-glucocorticoid-treated-osteonecrosis-of-the-femoral-head-have-a-higher-risk-of-in-hospital-reoperation-a-nationwide-propensity-score-matched-analysis/]]></guid>
			<link><![CDATA[https://czeek.com/ronbun/after-total-hip-arthroplasty-patients-with-glucocorticoid-treated-osteonecrosis-of-the-femoral-head-have-a-higher-risk-of-in-hospital-reoperation-a-nationwide-propensity-score-matched-analysis/]]></link>
			<title>After total hip arthroplasty, patients with glucocorticoid-treated osteonecrosis of the femoral head have a higher risk of in-hospital reoperation: a nationwide propensity score-matched analysis.</title>
			<pubDate><![CDATA[Mon, 15 Jun 2026 06:15:20 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://czeek.com/ronbun/virtual-internal-exposures-of-lansoprazole-administered-to-cytochrome-p450-2c19-poor-metabolizers-estimated-by-simplified-physiologically-based-pharmacokinetic-modeling/]]></guid>
			<link><![CDATA[https://czeek.com/ronbun/virtual-internal-exposures-of-lansoprazole-administered-to-cytochrome-p450-2c19-poor-metabolizers-estimated-by-simplified-physiologically-based-pharmacokinetic-modeling/]]></link>
			<title>Virtual internal exposures of lansoprazole administered to cytochrome P450 2C19 poor metabolizers estimated by simplified physiologically based pharmacokinetic modeling.</title>
			<pubDate><![CDATA[Mon, 15 Jun 2026 06:15:18 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://czeek.com/ronbun/association-between-immune-checkpoint-inhibitor-induced-myocarditis-and-concomitant-use-of-thiazide-diuretics/]]></guid>
			<link><![CDATA[https://czeek.com/ronbun/association-between-immune-checkpoint-inhibitor-induced-myocarditis-and-concomitant-use-of-thiazide-diuretics/]]></link>
			<title>Association between immune checkpoint inhibitor-induced myocarditis and concomitant use of thiazide diuretics.</title>
			<pubDate><![CDATA[Mon, 15 Jun 2026 06:15:18 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://czeek.com/ronbun/medication-errors-in-malaria-management-in-children-insights-from-pharmacovigilance-data-in-the-democratic-republic-of-congo/]]></guid>
			<link><![CDATA[https://czeek.com/ronbun/medication-errors-in-malaria-management-in-children-insights-from-pharmacovigilance-data-in-the-democratic-republic-of-congo/]]></link>
			<title>Medication errors in malaria management in children: insights from pharmacovigilance data in the Democratic Republic of Congo.</title>
			<pubDate><![CDATA[Mon, 15 Jun 2026 06:15:16 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://czeek.com/ronbun/a-global-population-based-study-on-the-association-between-ketamine-and-esketamine-with-suicidality-using-who-vigibase/]]></guid>
			<link><![CDATA[https://czeek.com/ronbun/a-global-population-based-study-on-the-association-between-ketamine-and-esketamine-with-suicidality-using-who-vigibase/]]></link>
			<title>A Global Population-Based Study on the Association Between Ketamine and Esketamine With Suicidality Using WHO VigiBase.</title>
			<pubDate><![CDATA[Mon, 15 Jun 2026 06:15:16 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://czeek.com/ronbun/safety-profile-of-belatacept-in-a-real-life-setting-disproportionality-analysis-of-the-who-pharmacovigilance-database/]]></guid>
			<link><![CDATA[https://czeek.com/ronbun/safety-profile-of-belatacept-in-a-real-life-setting-disproportionality-analysis-of-the-who-pharmacovigilance-database/]]></link>
			<title>Safety profile of belatacept in a real-life setting: disproportionality analysis of the WHO pharmacovigilance database.</title>
			<pubDate><![CDATA[Mon, 15 Jun 2026 06:15:13 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://czeek.com/ronbun/metoclopramide-and-risk-of-pheochromocytoma-crisis-a-causality-assessment-using-literature-and-vigibase-data/]]></guid>
			<link><![CDATA[https://czeek.com/ronbun/metoclopramide-and-risk-of-pheochromocytoma-crisis-a-causality-assessment-using-literature-and-vigibase-data/]]></link>
			<title>Metoclopramide and Risk of Pheochromocytoma Crisis: A Causality Assessment Using Literature and VigiBase Data.</title>
			<pubDate><![CDATA[Mon, 15 Jun 2026 06:15:10 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://czeek.com/ronbun/post-marketing-safety-profile-of-bictegravir-emtricitabine-tenofovir-alafenamide-a-faers-pharmacovigilance-study-with-eudravigilance-validation-and-mechanistic-investigation-of-pancreatitis/]]></guid>
			<link><![CDATA[https://czeek.com/ronbun/post-marketing-safety-profile-of-bictegravir-emtricitabine-tenofovir-alafenamide-a-faers-pharmacovigilance-study-with-eudravigilance-validation-and-mechanistic-investigation-of-pancreatitis/]]></link>
			<title>Post-marketing safety profile of bictegravir/emtricitabine/tenofovir alafenamide: a FAERS pharmacovigilance study with EudraVigilance validation and mechanistic investigation of pancreatitis.</title>
			<pubDate><![CDATA[Mon, 15 Jun 2026 06:14:58 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://czeek.com/ronbun/a-comparison-of-antibiotic-resistance-reports-in-pharmacovigilance-databases-and-conventional-surveillance-across-one-health/]]></guid>
			<link><![CDATA[https://czeek.com/ronbun/a-comparison-of-antibiotic-resistance-reports-in-pharmacovigilance-databases-and-conventional-surveillance-across-one-health/]]></link>
			<title>A comparison of antibiotic resistance reports in pharmacovigilance databases and conventional surveillance across &#8220;One Health&#8221;.</title>
			<pubDate><![CDATA[Mon, 15 Jun 2026 06:14:58 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://czeek.com/ronbun/occurrence-of-somnolence-and-respiratory-depression-induced-by-pregabalin-and-mirogabalin-use-and-the-influence-of-opioid-treatment-using-the-japanese-adverse-drug-event-report-database/]]></guid>
			<link><![CDATA[https://czeek.com/ronbun/occurrence-of-somnolence-and-respiratory-depression-induced-by-pregabalin-and-mirogabalin-use-and-the-influence-of-opioid-treatment-using-the-japanese-adverse-drug-event-report-database/]]></link>
			<title>Occurrence of somnolence and respiratory depression induced by pregabalin and mirogabalin use and the influence of opioid treatment using the Japanese adverse drug event report database.</title>
			<pubDate><![CDATA[Mon, 15 Jun 2026 06:14:57 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://czeek.com/ronbun/correction-endocrine-advantages-of-pd-1-pd-l1-therapy-comparative-analysis-of-faers-jader/]]></guid>
			<link><![CDATA[https://czeek.com/ronbun/correction-endocrine-advantages-of-pd-1-pd-l1-therapy-comparative-analysis-of-faers-jader/]]></link>
			<title>Correction: Endocrine advantages of PD-1/PD-L1 therapy: Comparative analysis of FAERS-JADER.</title>
			<pubDate><![CDATA[Mon, 15 Jun 2026 06:14:54 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://czeek.com/ronbun/efficacy-and-safety-of-repetitive-transcranial-magnetic-stimulation-in-anorexia-and-bulimia-nervosa-a-systematic-review-and-meta-analysis/]]></guid>
			<link><![CDATA[https://czeek.com/ronbun/efficacy-and-safety-of-repetitive-transcranial-magnetic-stimulation-in-anorexia-and-bulimia-nervosa-a-systematic-review-and-meta-analysis/]]></link>
			<title>Efficacy and safety of repetitive transcranial magnetic stimulation in anorexia and bulimia nervosa: a systematic review and meta-analysis.</title>
			<pubDate><![CDATA[Mon, 15 Jun 2026 06:14:53 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://czeek.com/ronbun/safety-profile-of-lipid-emulsion-in-clinical-practice-a-pharmacovigilance-study-using-the-fda-adverse-event-reporting-system/]]></guid>
			<link><![CDATA[https://czeek.com/ronbun/safety-profile-of-lipid-emulsion-in-clinical-practice-a-pharmacovigilance-study-using-the-fda-adverse-event-reporting-system/]]></link>
			<title>Safety Profile of Lipid Emulsion in Clinical Practice: A Pharmacovigilance Study Using the FDA Adverse Event Reporting System.</title>
			<pubDate><![CDATA[Mon, 15 Jun 2026 06:14:51 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://czeek.com/ronbun/association-of-non-steroidal-anti-inflammatory-drug-use-with-encephalopathy-development-an-analysis-using-the-united-states-food-and-drug-administration-adverse-event-reporting-system-faers-and-jap/]]></guid>
			<link><![CDATA[https://czeek.com/ronbun/association-of-non-steroidal-anti-inflammatory-drug-use-with-encephalopathy-development-an-analysis-using-the-united-states-food-and-drug-administration-adverse-event-reporting-system-faers-and-jap/]]></link>
			<title>Association of non-steroidal anti-inflammatory drug use with encephalopathy development: An analysis using the United States Food and Drug Administration Adverse Event Reporting System (FAERS) and Japanese Adverse Drug Event Report (JADER) databases.</title>
			<pubDate><![CDATA[Mon, 15 Jun 2026 06:14:50 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://czeek.com/ronbun/analysis-of-the-incidence-and-factors-influencing-medication-administration-errors-among-nurses-a-retrospective-study/]]></guid>
			<link><![CDATA[https://czeek.com/ronbun/analysis-of-the-incidence-and-factors-influencing-medication-administration-errors-among-nurses-a-retrospective-study/]]></link>
			<title>Analysis of the Incidence and Factors Influencing Medication Administration Errors Among Nurses: A Retrospective Study.</title>
			<pubDate><![CDATA[Mon, 15 Jun 2026 06:14:49 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://czeek.com/ronbun/drug-risks-associated-with-sarcopenia-a-real-world-and-gwas-study/]]></guid>
			<link><![CDATA[https://czeek.com/ronbun/drug-risks-associated-with-sarcopenia-a-real-world-and-gwas-study/]]></link>
			<title>Drug risks associated with sarcopenia: a real-world and GWAS study.</title>
			<pubDate><![CDATA[Mon, 15 Jun 2026 06:14:49 +0000]]></pubDate>
		</item>
				</channel>
</rss>
